TABLE 2.
Grade ≥ 3 adverse events at least possibly drug related
| Adverse event | Number of patients (%) |
|---|---|
| Respiratory failure | |
| Grade 5 | 1 (7%) |
| Neutropenia | |
| Grade 4 | 1 (7%) |
| Grade 3 | 3 (20%) |
| Lymphopenia | |
| Grade 4 | 1 (7%) |
| Grade 3 | 2 (13%) |
| Leukopenia | |
| Grade 4 | 1 (7%) |
| Diarrhea | |
| Grade 3 | 1 (7%) |
| Fatigue | |
| Grade 3 | 2 (13%) |
| Infusion reaction | |
| Grade 3 | 1 (7%) |
| Alanine aminotransferase increased | |
| Grade 3 | 1 (7%) |
| Weight loss | |
| Grade 3 | 1 (7%) |
| Hypertriglyceridemia | |
| Grade 3 | 1 (7%) |
| Hyponatremia | |
| Grade 3 | 1 (7%) |
| Thromboembolic event | |
| Grade 3 | 1 (7%) |
| Palmar‐plantar erythrodysesthesia | |
| Grade 3 | 1 (7%) |
| Hypertension | |
| Grade 3 | 3 (20%) |
Note: Data cutoff date.